Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28
U.S. Healthcare Sector Analysis
UpdatedNov 30, 2022
DataAggregated Company Financials
Companies1566
- 7D-0.04%
- 3M5.9%
- 1Y-8.3%
- YTD-11.8%
Over the last 7 days, the Healthcare industry has remained flat. Unfortunately though, the industry is down 8.3% over the past 12 months. As for the next few years, earnings are expected to grow by 13% per annum.
Sector Valuation and Performance
Has the U.S. Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 30 Nov 2022 | US$6.0t | US$2.4t | US$133.6b | 23.7x | 44.7x | 2.5x |
| Fri, 28 Oct 2022 | US$5.8t | US$2.4t | US$153.3b | 22.6x | 38x | 2.4x |
| Sun, 25 Sep 2022 | US$5.5t | US$2.4t | US$155.9b | 20.7x | 35.4x | 2.3x |
| Tue, 23 Aug 2022 | US$6.0t | US$2.4t | US$156.9b | 23.6x | 37.9x | 2.5x |
| Thu, 21 Jul 2022 | US$5.9t | US$2.6t | US$164.0b | 24.8x | 35.8x | 2.3x |
| Sat, 18 Jun 2022 | US$5.4t | US$2.6t | US$165.3b | 23.1x | 32.4x | 2.1x |
| Mon, 16 May 2022 | US$5.7t | US$2.6t | US$164.8b | 25x | 34.9x | 2.2x |
| Wed, 13 Apr 2022 | US$6.5t | US$2.5t | US$175.5b | 29x | 37x | 2.6x |
| Fri, 11 Mar 2022 | US$6.2t | US$2.5t | US$170.8b | 28.1x | 36.1x | 2.5x |
| Sun, 06 Feb 2022 | US$6.3t | US$2.4t | US$165.0b | 29.7x | 38.2x | 2.6x |
| Tue, 04 Jan 2022 | US$6.9t | US$2.4t | US$145.5b | 33x | 47.3x | 2.9x |
| Thu, 02 Dec 2021 | US$6.6t | US$2.4t | US$146.5b | 30.8x | 44.8x | 2.7x |
| Sat, 30 Oct 2021 | US$6.8t | US$2.3t | US$130.2b | 34x | 52.6x | 2.9x |
| Mon, 27 Sep 2021 | US$6.9t | US$2.3t | US$120.0b | 36.1x | 57.2x | 3x |
| Wed, 25 Aug 2021 | US$6.9t | US$2.3t | US$121.2b | 32.7x | 57.1x | 3x |
| Thu, 01 Jul 2021 | US$6.6t | US$2.3t | US$113.6b | 32.4x | 57.7x | 2.9x |
| Sun, 04 Apr 2021 | US$6.0t | US$2.4t | US$93.5b | 29x | 64.1x | 2.5x |
| Wed, 06 Jan 2021 | US$5.8t | US$2.3t | US$87.0b | 29.3x | 66.5x | 2.5x |
| Sat, 10 Oct 2020 | US$5.1t | US$2.3t | US$104.6b | 28.7x | 49.1x | 2.3x |
| Fri, 03 Jul 2020 | US$4.8t | US$2.4t | US$101.2b | 31.4x | 47.4x | 2x |
| Mon, 06 Apr 2020 | US$3.9t | US$2.4t | US$99.2b | 28.8x | 39x | 1.6x |
| Thu, 09 Jan 2020 | US$4.5t | US$2.3t | US$100.0b | 29.1x | 44.5x | 1.9x |
Price to Earnings Ratio
46.5x
Current Industry PE
- Investors are pessimistic on the American Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 44.7x which is lower than its 3-year average PE of 48.1x.
- The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 13% per year over the last three years.
- Revenues for these companies have grown 2.8% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare sector?
| US Market | -0.94% | |
| Healthcare | -0.045% | |
| Healthcare Services | 1.05% | |
| Pharma | 0.49% | |
| Medical Equipment | 0.07% | |
| Healthtech | -0.35% | |
| Biotech | -1.00% | |
| Life Sciences | -1.67% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 9.4%, which is lower than the prior year's growth of 60.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 36% over the next 5 years.
- This is better than its past earnings growth rate of 28% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 9.4% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MRK Merck | US$108.84 | 1.8% +US$4.9b | 45.3% | PE18x | |
| UNH UnitedHealth Group | US$528.00 | 0.9% +US$4.6b | 18.9% | PE25.4x | |
| LLY Eli Lilly | US$363.95 | 0.9% +US$2.9b | 46.7% | PE57.3x | |
| ELV Elevance Health | US$515.36 | 2.0% +US$2.5b | 26.9% | PE19.8x | |
| PFE Pfizer | US$49.49 | 0.8% +US$2.3b | -7.9% | PE9.3x |
